Alclofenac

This classification denotes an anti-inflammatory agent with the molecular formula C11H11ClO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M9CP5H21N8, chemically known as benzeneacetic acid, 3-chloro-4-(2-propenyloxy)- but generally known as alclofenac, which bears US NIH Compound Identifier 30951. Alclofenac comes in many forms, including epoxide, monoethanolamine complex, and sodium. European Medicines Agency schedules Alclofenac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05299MIG. The term ALCLOFENAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules alclofenac in its Anatomical Therapeutic Chemical (ATC) Classification. ALCLOFENAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alclofenac under HS 29189900 and SITC 51396. As of Q4 2014, ALCLOFENAC remains the US FDA Preferred Term for this commodity. SMILES: C=CCOC1=C(C=C(C=C1)CC(=O)O)CL.